A pioneering research and development (R&D) company at the forefront of biotechnology innovation. With a passion for driving advancements in the life sciences, our multidisciplinary team of experts combine cutting-edge knowledge with unrivalled consultancy services. At iNatural Ltd, we specialise in the production and characterisation of biosynthetic polymeric materials for biomedical applications. Our scientific team also specialise in gut Health and Biomedical Research, revolutionising the way we understand and harness the potential of the human microbiome. Through our collaborative approach and dedication to scientific excellence, we strive to shape a healthier and more sustainable future for all.
• Natural cellulose-based biosynthetic polymers have emerged as a remarkable innovation with profound potential for transformative medical applications. At iNatural Ltd, we are passionately dedicated to exploring the vast capabilities of these biomaterials and harnessing their unique properties to revolutionise the field of medicine.
• Plant cellulose, a naturally abundant and renewable biopolymer is commonly used in wound dressings. We specialise in biosynthetic ultra-pure cellulose produced by various bacterial strains, serving as the cornerstone of our research endeavours.
• Through advances in biotechnology and material science, at iNatural Ltd we aim to unlock the full therapeutic potential of cellulose-based biosynthetic polymers, paving the way for a new era of regenerative medicine, drug delivery systems, and biomedical devices.
In the evolving scientific advancements, nanotechnology has attracted a wide research interest in the biomedical field. At the heart of this trailblazing endeavour lies a firm commitment to an environmentally friendly approach. Through cutting-edge research and sustainable practices, our scientists and innovators are revolutionising the way nanoparticles are synthesised, ensuring minimal ecological impact. These nanoparticles, produced using natural products have unique properties, advocating their potential applications in the biomedical sector. In this exploration of nanoparticle technology, we delve into the ingenious amalgamation of environmentally conscious production techniques and their extraordinary applications in the biomedical field, paving the way for a brighter, greener, and healthier future.
Multiple drug resistance has encouraged scientist to look for antibiotic alternatives for controlling infections. Mother nature has provided many natural products with antimicrobial, healing and remedial properties for biomedical applications. At iNatural Ltd, our scientists specialise in selecting these natural potent materials, converting the active compounds into suitable formulations, using appropriate techniques, and evaluating their biological compatibility, to enhance their translational biomedical application potential. At iNatural Ltd., our research team specialise in using natural products for wound health and for gut health, as prebiotics. We are actively involved in research and development in these biomedical sectors.
• In the realm of nutrition and digestive health, prebiotics have gained significant attention for their beneficial impact on the gut microbiome. Various plant-based sources serve as a nourishing substrate for beneficial gut bacteria, fostering their growth and activity and promote overall well-being.
• Psyllium husk, derived from the seeds of the Plantago ovata plant, is rich in soluble fibre and renowned for its capacity to enhance bowel movements and alleviate constipation.
• Inulin, a naturally occurring carbohydrate found in various plant sources, is used to enrich food with natural fibres. Together, these prebiotic powerhouses offer a compelling synergy that can positively influence our digestive health and pave the way for a more balanced and vibrant lifestyle.
iNatural Ltd is at the forefront of innovative research and development in biosynthetic polymers, gut health, food supplements, and nanotechnology. With a team of accomplished scientists and clinicians, we bring forth a groundbreaking idea aimed at making a meaningful contribution to a brighter future. Sustainability in biomedical research involves integrating environmentally conscious practices and responsible resource management to advance scientific discoveries while minimising the impact on the natural world. At iNatural Ltd., environmental sustainability lies at the heart of everything we do. We are driven by a deep-rooted commitment to an environment-friendly approach that guides our innovation and decision-making processes.
Dr Abhishek Gupta, our Chief Scientific Officer (CSO) is an experienced researcher and educator with international track record in the production and characterisation of biosynthetic polymers for potential biomedical applications. Dr Gupta has many peer-reviewed international publications in his account. Along with nanotechnology, Dr Gupta specialise in natural products with biomedical remediation applications. He has presented his research at several national and international conferences and won many awards. He has research collaborations in several countries. Dr Abhishek Gupta’s passion for scientific discovery, to help treatments for vital areas of medicine, is globally recognised, including the regional Express and Star newspaper. He was presented with the highest diasporic award, Hind Rattan Award by the NRI Welfare Society in 2021 and the prestigious International Education Award during the Global Education Summit and Conference at the University of Oxford. Dr Gupta has expertise in nanotechnology with intended biomedical applications. His published research work has been placed in the top 1% of the academic field of Biology & Biochemistry based on a highly cited threshold for the filed and publication year.
In the world of entrepreneurship and scientific exploration, age knows no boundaries, and innovation knows no age. Krish's fascination with the biomedical realm began when he was just 6 years old. During his early year of primary school, he confidently presented on the cardiovascular system, digestive system, and skeletal system. Fast forward to the present, at 16 years old, Krish has taken his curiosity to a whole new level by establishing iNatural Ltd. Krish Gupta is a visionary prodigy who defies conventional norms and has embarked on an extraordinary journey to revolutionise the landscape of gut health, biotechnology, and research. As the Director and Founder of iNatural Ltd, Krish brings a fresh perspective and boundless curiosity to the realm of scientific discovery. With an insatiable thirst for knowledge and an unwavering passion for making a positive impact, Krish has fearlessly taken the helm, determined to pave the way for groundbreaking advancements in gut health and biotechnology.
Dr Brian Johnston is a Biotechnology Research Associate and the founder of iBiotech. He holds a PhD in Microbiology and Biotechnology that he earned in 2020. During his PhD, he focused on the development of innovative methods to recycle a variety of waste plastic carbon sources for the biological synthesis of bioplastics. The bioplastic materials that resulted from his research have since found application in several sectors, including agriculture, fashion and medicine. Dr. Johnston has authored over 20 publications and received multiple citations in international scientific journals. He has also worked on two post-doctoral placements, with projects supported by both the EU and Midlands Engine. Furthermore, he has established a network of academic and industrial partnerships, including institutions such as SINTEF (Norway) and the Polish Academy of Sciences (PAN).
Dr Dimple Sethi Chopra is presently working as Associate Professor (Pharmaceutics) in Department of Pharmaceutical Sciences and Drug Research (DPDSR), Punjabi University, Patiala. Her present areas of interest are biomaterial research, developing nanocarriers for probiotic DNA, development of herbal wound dressings for burn injury, designing nanocarriers to overcome antimicrobial antimicrobial resistance, pharmacokinetics, green nanotechnology, molecular nanotechnology, targeted drug delivery, nanobiotechnology and nanomedicine. She supervised a Ph.D thesis on “Preparation And Characterization of Probiotic DNA Loaded Chitosan Nanoparticles And Their Application In Modification of Selected Immunological Disorders” Her research interest includes exploring different types of nanoparticles for treatment of dementia related to various neurodegenerative disorders like Alzheimer’s disease. She is also actively engaged in developing nanocarrier systems for treatment of rheumatoid arthritis and osteoarthritis. She has also worked on other particulate systems like microspheres and niosomes for development of controlled drug delivery systems for oral as well as topical use. She has published several research papers in national and international journals of repute. She has three books to her credit. She has several open access peer reviewed book chapters to her credit with publishing houses like IGI Global, INTECH OPEN, Studium Press LLC, USA, McGraw Hill Education (India) Private Ltd, New Delhi. She has presented her work at several national and international conferences. She is an active participant of Asia Pacific Advanced Network (APAN). She has been granted two Indian patents on brain permeable nanoparticles. She is an invited manuscript reviewer of many international journals like Drug Discovery today, Journal of Nanoparticle Research, drug delivery, seizure, Open Access Rheumatology: Research and Reviews, International Journal of Nanomedicine, Drug Design, Development and Therapy. She is a member of American Nano Society.She is on editorial board of many international journals.
Dr Hitender Suri is a highly competent doctor, who founded Rana Piles Hospital - a premier hospital in North India for the treatment of Hemorrhoids/Piles, Fissures and Fistula. Dr Hitender Suri has been making India proud with his revolutionary innovations for the past 20 years. Dr Suri has his name registered in the coveted ‘Guinness Book of World Records’ for motivating over 1.25 lakh people as part of "Eat fibre, Stay healthy" movement. He is also renowned for inventing India's first home-care Piles device in India called 'GMS Piles Relief Device' which got recognised at ISURC Conference in London. He holds multiple national and international records and has many publications to his name.
Anil has forged a path of success in not just one, but three distinct domains. As a passionate environmental advocate, Anil founded his own recycling plastic company, JKM Industries in India, pioneering sustainable solutions in the face of the global plastic crisis. Simultaneously, his knowledge as a qualified pharmacist led him to establish a thriving pharmaceutical company, Nicsol Pharmaceuticals operating in India. But the boundaries of his impact don't end there. Across the seas, Anil also plays a pivotal role as the International Operations Manager in iNatural Ltd. His unwavering dedication to fostering a greener, healthier world and his innate ability to navigate diverse industries make him an inspiring figure in the entrepreneurial landscape.
With determination and adaptability, Neeru embraced her role as an administrator in iNatural Ltd. Her innate organisational skills are vital for routine operations of our company. From managing schedules to facilitating communication, Neeru is the glue that holds our operations together.
Khushboo is a self-driven medical student currently pursuing her studies at the Royal College of Surgeons in Ireland (MB, BCh, BAO). She is a recipient of several academic awards including the National Book Award from the University of Toronto. With a strong passion for surgery, she aspires to become a skilled and specialized surgeon with a deep commitment to making a positive impact on the lives of others. Alongside her academic pursuits, Khushboo actively engages in various academic committees, volunteer activities, conducts research, and pursues personal hobbies that enrich her life. Khushboo is involved in numerous research projects with her most recent one being on melanoma care post COVID. Her diverse experiences have granted her a unique perspective, having navigated both the Canadian and European medical systems. Throughout her academic and clinical experiences, she has developed a strong foundation in medical science. Khushboo has observed several medical specialties including gastroenterology, dermatology, vascular surgery, endocrinology, and otolaryngology; this has provided her with valuable insights across various medical specialties.
At iNatural Ltd., collaboration is at the heart of our commitment to innovation and excellence. We are proud to partner with esteemed institutions and organisations that share our dedication to advancing healthcare solutions. Our partnership with the University of Wolverhampton brings a wealth of academic knowledge and research capabilities to our projects. Our association with international partners like the Punjabi University, India enriches our global perspective and cultural diversity. Together, these collaborations empower us to contribute to the well-being of individuals worldwide.
Wound care's significance has surged within the healthcare sector, primarily driven by the rising prevalence of chronic wounds in vulnerable populations such as the elderly, immunocompromised individuals, and obese patients. Additionally, the global diabetic incidence, as reported by the World Health Organization, has climbed from 108 million in 1980 to 422 million in 2014, further accentuating the need for advanced wound treatment. The management of wound care presents a significant challenge, evident in the 2022 global market estimate exceeding $20.8 billion, and it is expected to rise to approximately $27.2 billion by 2027.
Numerous adults are uninformed about their gut health The adult human gut houses trillions of microorganisms, encompassing over 1,000 species, forming a symbiotic relationship with the host. This intestinal microflora plays a crucial role in digestion, nutrient absorption, immune system regulation, and Wound Care. Dysbiosis, an imbalance in this ecosystem can result from loss of beneficial organisms or excessive growth of potentially harmful organisms. It is associated with diseases like Inflammatory Bowel Disease, obesity, Type 1 diabetes, and colorectal cancer in humans. Elements such as insufficient sleep, heightened stress levels, antibiotic use, and an unhealthy diet can influence the gut health. Should you observe indicators of compromised gut health, modifying lifestyle factors could enhance your gut microbiome and contribute to your overall well-being. Eating healthy diet with a good balance of prebiotics and probiotics can help balance gut microflora. In 2021, the global prebiotics market attained a worth of $6.05 billion, and it is anticipated to demonstrate a compound annual growth rate (CAGR) of 14.9% from 2022 to 2030. Concurrently, the probiotics market is experiencing rapid expansion, with an expected CAGR of 8.1% between 2022 and 2027.
Gupta, A. et al., 2020. Synthesis of Silver Nanoparticles Using Curcumin-Cyclodextrins Loaded into Bacterial Cellulose Based Hydrogels for Wound Dressing Applications. BioMacromolecules, 21(5), pp. 1802–1811 Want to know more? Click here
Gupta, A. et al., 2020. Synthesis of Silver Nanoparticles Using Curcumin-Cyclodextrins Loaded into Bacterial Cellulose Based Hydrogels for Wound Dressing Applications. BioMacromolecules, 21(5), pp. 1802–1811
Gupta, A. et al., 2019. Production and characterisation of bacterial cellulose hydrogels loaded with curcumin encapsulated in Cyclodextrins as wound dressings. European Polymer Journal, 118, pp. 437-450 Want to know more? Click here
Gupta, A. et al., 2019. Production and characterisation of bacterial cellulose hydrogels loaded with curcumin encapsulated in Cyclodextrins as wound dressings. European Polymer Journal, 118, pp. 437-450
Gupta, A. et al., 2019. The production and application of hydrogels for wound management- A review. European Polymer Journal, 111, pp.134-151. Want to know more? Click here
Gupta, A. et al., 2019. The production and application of hydrogels for wound management- A review. European Polymer Journal, 111, pp.134-151.
Gupta, A. et al., 2017. Physicochemical characterisation of biosynthetic bacterial cellulose as a potential wound dressing material. British Journal of Pharmacy, 2(2), pp. S37-38. Want to know more? Click here
Gupta, A. et al., 2017. Physicochemical characterisation of biosynthetic bacterial cellulose as a potential wound dressing material. British Journal of Pharmacy, 2(2), pp. S37-38.
Gupta, A. et al., 2016. Characterisation and in vitro antimicrobial activity of biosynthetic silver-loaded bacterial cellulose hydrogels. Journal of Microencapsulation, 33(8), pp. 725-734. DOI: Want to know more? Click here
Gupta, A. et al., 2016. Characterisation and in vitro antimicrobial activity of biosynthetic silver-loaded bacterial cellulose hydrogels. Journal of Microencapsulation, 33(8), pp. 725-734. DOI:
Chopra D, et al., 2008. Use of Liposomal Drugs in the treatment of Rheumatoid Arthritis. Current Rheumatology Reviews 2008; 4(1), pp. 63-70. DOI: Want to know more? Click here
Chopra D, et al., 2008. Use of Liposomal Drugs in the treatment of Rheumatoid Arthritis. Current Rheumatology Reviews 2008; 4(1), pp. 63-70. DOI:
Chopra D, et al., 2008. Thermal and Isothermal Methods in Development of Sustained Release Dosage Forms of Ketorolac Tromethamine. E-J.Chem; 5(2), pp.316-322. Want to know more? Click here
Chopra D, et al., 2008. Thermal and Isothermal Methods in Development of Sustained Release Dosage Forms of Ketorolac Tromethamine. E-J.Chem; 5(2), pp.316-322.
Chopra, D. et al., 2008. Brain Permeable Nanoparticles. Recent Patents on CNS Drug Discovery (ISSN: 1574-8898) 2008; 3(3), pp. 216-225.